<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03283306</url>
  </required_header>
  <id_info>
    <org_study_id>B-1607-356-304</org_study_id>
    <nct_id>NCT03283306</nct_id>
  </id_info>
  <brief_title>Prognostic Value of Carotid CEUS in Acute Ischemic Stroke Patients</brief_title>
  <official_title>Prognostic Value of Carotid Contrast-Enhanced Ultrasound in Acute Ischemic Stroke Patients for Cerebrovascular and Cardiovascular Event</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Foundation of Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Contrast-enhanced ultrasound(CEUS) of carotid artery plaque is a novel method that enabled
      direct visualization of neovessels in the vulnerable plaque. Plaque enhancement with CEUS
      showed correlation with the histologic density of neovessels within the carotid plaque and
      the previous cardiovascular events. Vulnerable plaques with a high risk of thromboembolic
      complications and rapid progression is associated with acute ischemic stroke. The prognostic
      value of vulnerable carotid artery plaque depicted with CEUS has not been fully investigated.
      The purpose of this study is to define prognostic value of plaque enhancement on carotid CEUS
      in acute stroke patients. Research question is; in acute ischemic stroke patients with
      ipsilateral carotid plaque as probable etiology of stroke, is the presence of carotid plaque
      enhancement on CEUS independent predictor of future stroke.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 9, 2017</start_date>
  <completion_date type="Anticipated">September 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Composite of recurrent stroke, vascular death and myocardial infarction</measure>
    <time_frame>12 months</time_frame>
    <description>(1) recurrent stroke: newly appeared DWI positive lesion on brain MRI with corresponding neurologic symptom (2) vascular death: sudden death, death due to stroke, myocardial infarction, heart failure, arrhythmia, pulmonary embolism, systemic bleeding, or ischemia of organ. (3) myocardial infarction: at least two of the followings: ① a history of typical angina pain. ② Elevation of Troponin, ③ Newly developed ST change or Q waves or LBBB on ECG (outcomes will be measured by chart review or physician diagnosis or telephone interview)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ipsilateral stroke</measure>
    <time_frame>12 months</time_frame>
    <description>Recurrent stroke of ipsilateral side (recurrent stroke at same side of previous infarction)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>12 months</time_frame>
    <description>All of the deaths, regardless of the cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Carotid intervention</measure>
    <time_frame>12 months</time_frame>
    <description>Ipsilateral carotid endarterectomy or carotid artery stent insertion which was not planned when discharge.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">667</enrollment>
  <condition>Ultrasonography</condition>
  <condition>Carotid Stenosis</condition>
  <condition>Ischemic Stroke</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized acute ischemic stroke patients with ipsilateral carotid artery stenosis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients older than 19 years presenting acute ischemic stroke.

          2. Compatible neurologic symptom within 14 days

          3. Compatible MRI finding (one or more positive DWI lesions in the territory of
             unilateral ICA: ACA or MCA territory) - interpretable MRI image obtained in SNUBH or
             outside hospital

          4. Etiology of acute ischemic stroke: except cardioembolic stroke (Atrial fibrillation)
             and other determined etiology

          5. Ipsilateral extracranial carotid artery stenosis on MRA (CE-MRA), CTA or Doppler
             ultrasound

        Exclusion Criteria:

          1. History of ipsilateral carotid stent or endarterectomy

          2. Carotid intervention during hospital stay

          3. Contraindication to ultrasound contrast agent (SonoVue) A. Right to left,
             bi-directional, or transient right to left cardiac shunts B. History of
             hypersensitivity reactions to sulfur hexafluoride lipid microsphere components or any
             ultrasound contrast agent C. Pregnant or lactating woman D. Unstable cardiopulmonary
             conditions (acute myocardial infarction, acute coronary artery syndromes, worsening
             congestive heart failure, or serious ventricular arrhythmias)

          4. Expected life span less than 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yeo Koon Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yeo Koon Kim, MD</last_name>
    <phone>82-10-3460-0660</phone>
    <email>yeokoon@snubh.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eun Jung Kim</last_name>
    <phone>82-10-2450-3988</phone>
    <email>jfhg92@naver.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yumi Kim</last_name>
      <phone>+82-31-787-8872</phone>
      <email>98716@snubh.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 11, 2017</study_first_submitted>
  <study_first_submitted_qc>September 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2017</study_first_posted>
  <last_update_submitted>September 12, 2017</last_update_submitted>
  <last_update_submitted_qc>September 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Yeo Koon Kim</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

